| pubmed-article:11072595 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11072595 | lifeskim:mentions | umls-concept:C0024141 | lld:lifeskim |
| pubmed-article:11072595 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:11072595 | lifeskim:mentions | umls-concept:C0002351 | lld:lifeskim |
| pubmed-article:11072595 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:11072595 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:11072595 | lifeskim:mentions | umls-concept:C1327413 | lld:lifeskim |
| pubmed-article:11072595 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11072595 | pubmed:dateCreated | 2001-2-5 | lld:pubmed |
| pubmed-article:11072595 | pubmed:abstractText | T cell abnormalities, B cell hyperactivity and abnormal cytokine production have been implicated to be of pathogenic importance in systemic lupus erythematosus (SLE). The aim of this study was to investigate if ongoing production and serum levels of type 1 and 2 cytokines reflect disease activity and the presence of organ manifestations. | lld:pubmed |
| pubmed-article:11072595 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11072595 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11072595 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11072595 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11072595 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11072595 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11072595 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11072595 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11072595 | pubmed:issn | 0392-856X | lld:pubmed |
| pubmed-article:11072595 | pubmed:author | pubmed-author:KlareskogLL | lld:pubmed |
| pubmed-article:11072595 | pubmed:author | pubmed-author:LundbergII | lld:pubmed |
| pubmed-article:11072595 | pubmed:author | pubmed-author:RönnelidJJ | lld:pubmed |
| pubmed-article:11072595 | pubmed:author | pubmed-author:GunnarssonII | lld:pubmed |
| pubmed-article:11072595 | pubmed:author | pubmed-author:RogbergSS | lld:pubmed |
| pubmed-article:11072595 | pubmed:author | pubmed-author:GröndalGG | lld:pubmed |
| pubmed-article:11072595 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11072595 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:11072595 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11072595 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11072595 | pubmed:pagination | 565-70 | lld:pubmed |
| pubmed-article:11072595 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:meshHeading | pubmed-meshheading:11072595... | lld:pubmed |
| pubmed-article:11072595 | pubmed:articleTitle | Cytokine production, serum levels and disease activity in systemic lupus erythematosus. | lld:pubmed |
| pubmed-article:11072595 | pubmed:affiliation | Department of Rheumatology, Karolinska Hospital, Stockholm, Sweden. | lld:pubmed |
| pubmed-article:11072595 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11072595 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11072595 | lld:pubmed |
